Safety and tolerability of risedronate in the treatment of osteoporosis in patients with renal insufficiency.

被引：0
|
作者：
Delaney, MF
Hurwitz, S
Carey, JJ
机构：
[1] Brigham & Womens Hosp, Endocrinol Diabet & Hypertens Div, Boston, MA 02115 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [41] Delayed use of tacrolimus in orthotopic liver transplant patients with renal insufficiency.
    Johnson, M
    Salm, J
    Taber, D
    Schoots, M
    Hollar, K
    Dupuis, R
    Gerber, D
    Meehan, A
    Shrestha, R
    Zacks, S
    Fair, J
    TRANSPLANTATION, 2000, 69 (08) : S169 - S169
  • [42] Mechanism of elevated serum chromogranin A in renal insufficiency.
    Mojiminiyi, OA
    Al Suleiman, A
    George, S
    CLINICAL CHEMISTRY, 1998, 44 : A143 - A143
  • [43] Evaluation of bleeding incidence and prescribing pattern of enoxaparin in patients with renal insufficiency.
    Chung, EP
    Achio, H
    Hidayat, LK
    PHARMACOTHERAPY, 2005, 25 (10): : 1452 - 1452
  • [44] DENOSUMAB FORTHE TREATMENT OF OSTEOPOROSIS IN PATIENTS WITH RENAL INSUFFICIENCY WITH AND WITHOUT PRIMARY HYPERPARATHYROIDISM
    Gronskaya, S.
    Rozhinskaya, L.
    Mamedova, E.
    Vorotsova, M.
    Melnichenko, G.
    Belaya, Z.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S197 - S197
  • [45] Concerning a case of acute traumatic renal insufficiency.
    Beuster, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1910, 36 : 841 - 843
  • [46] Hyperhomocysteinemia in predialysis and posttransplant chronic renal insufficiency.
    Dellanna, F
    Kissinger, GL
    Pollok, M
    Switkowski, R
    Baldamus, CA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0318 - A0318
  • [47] Zoledronic acid in older patients with osteoporosis: Safety and tolerability
    Inderjeeth, C. A.
    So, K.
    Bates, J.
    Van, V.
    BONE, 2011, 48 : S215 - S215
  • [48] Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis
    Harris, ST
    Watts, NB
    Li, Z
    Chines, AA
    Hanley, DA
    Brown, JP
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (05) : 757 - 764
  • [49] EVALUATION OF PHARMACEUTICAL INTERVENTIONS IN PATIENTS WITH RENAL INSUFFICIENCY. RECORDING IN AN ELECTRONIC PRESCRIPTION PROGRAM
    Esther, Ramirez Herraiz
    Ainoha, Aranguren Oyarzabal
    Helena, Casas Agudo
    Amparo, Ibanez Zurriaga
    Alberto, Morell Baladron
    ATENCION FARMACEUTICA, 2010, 12 (03): : 189 - 192
  • [50] Efficacy, tolerability, and safety of risedronate in Japanese patients with Paget's disease of bone
    Yoh, Kousei
    Takata, Shinjiro
    Yoshimura, Noriko
    Hashimoto, Jun
    JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (04) : 468 - 476
12345